Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7947) 7947
Magazine Article (44) 44
Book / eBook (7) 7
Dissertation (5) 5
Book Chapter (4) 4
Government Document (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (5363) 5363
science & technology (4773) 4773
life sciences & biomedicine (4708) 4708
humans (4706) 4706
animals (3705) 3705
anti-anxiety agents - pharmacology (3235) 3235
biological and medical sciences (3011) 3011
female (2922) 2922
medical sciences (2827) 2827
anti-anxiety agents - administration & dosage (2519) 2519
pharmacology & pharmacy (2375) 2375
pharmacology. drug treatments (2304) 2304
adult (2273) 2273
anti-anxiety agents - therapeutic use (2271) 2271
rats (2038) 2038
psychology. psychoanalysis. psychiatry (1837) 1837
neurosciences & neurology (1811) 1811
neuropharmacology (1770) 1770
neurosciences (1702) 1702
benzodiazepines (1634) 1634
psychopharmacology (1572) 1572
middle aged (1479) 1479
psychiatry (1458) 1458
anxiety (1404) 1404
dose-response relationship, drug (1296) 1296
mice (1235) 1235
psycholeptics: tranquillizer, neuroleptic (1110) 1110
anti-anxiety agents - adverse effects (1062) 1062
anxiety - drug therapy (1022) 1022
behavior, animal - drug effects (953) 953
aged (921) 921
double-blind method (815) 815
time factors (765) 765
rats, wistar (734) 734
motor activity - drug effects (722) 722
adolescent (720) 720
diazepam - pharmacology (714) 714
administration, oral (614) 614
anxiety disorders - drug therapy (570) 570
anti-anxiety agents (566) 566
maze learning - drug effects (554) 554
treatment outcome (540) 540
rats, sprague-dawley (531) 531
diazepam (522) 522
anti-anxiety agents - pharmacokinetics (500) 500
behavioral sciences (486) 486
abridged index medicus (456) 456
clinical neurology (449) 449
disease models, animal (442) 442
drug interactions (424) 424
analysis (416) 416
antianxiety agents (414) 414
anxiety - psychology (397) 397
drug administration schedule (379) 379
anti-anxiety agents - metabolism (363) 363
child (358) 358
diazepam - administration & dosage (344) 344
brain - drug effects (333) 333
antidepressive agents - therapeutic use (331) 331
antidepressants (325) 325
anti-anxiety agents - blood (324) 324
psychopathology. psychiatry (319) 319
drug therapy, combination (313) 313
fundamental and applied biological sciences. psychology (312) 312
analysis of variance (309) 309
antidepressive agents - pharmacology (309) 309
hypnotics and sedatives - administration & dosage (301) 301
exploratory behavior - drug effects (300) 300
brain - metabolism (299) 299
kinetics (292) 292
drug therapy (290) 290
anxieties (285) 285
psychology (281) 281
research (281) 281
clinical trials as topic (280) 280
social sciences (279) 279
benzodiazepines - administration & dosage (272) 272
benzodiazepine (269) 269
midazolam - administration & dosage (269) 269
toxicology (266) 266
anxiolytic (262) 262
rats, inbred strains (261) 261
depression (260) 260
midazolam (255) 255
lorazepam - administration & dosage (254) 254
care and treatment (249) 249
general & internal medicine (248) 248
anxiolytics (245) 245
half-life (244) 244
benzodiazepines - pharmacology (241) 241
chemistry, medicinal (241) 241
stress (241) 241
biomedicine (240) 240
sleep - drug effects (238) 238
diazepam - therapeutic use (234) 234
miscellaneous (233) 233
neurology (233) 233
injections, intravenous (231) 231
psychiatric status rating scales (231) 231
plant extracts - pharmacology (229) 229
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7349) 7349
Russian (251) 251
German (150) 150
French (141) 141
Japanese (137) 137
Italian (43) 43
Spanish (40) 40
Portuguese (23) 23
Hungarian (22) 22
Norwegian (21) 21
Danish (19) 19
Polish (19) 19
Chinese (14) 14
Dutch (9) 9
Swedish (7) 7
Finnish (6) 6
Czech (4) 4
Hebrew (3) 3
Turkish (3) 3
Bulgarian (2) 2
Romanian (2) 2
Ukrainian (2) 2
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube
by Podilsky, Gregory and Berger-Gryllaki, Markoulina and Testa, Bernard and Buclin, Thierry and Roulet, Michel and Pannatier, Andre
European journal of clinical pharmacology, ISSN 0031-6970, 5/2009, Volume 65, Issue 5, pp. 435 - 442
Omeprazole | Bromazepam | Paracetamol | Biomedicine | Bioavailability | Nasogastric route | Oral route | Pharmacology/Toxicology | Pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Anti-Anxiety Agents - administration & dosage | Prospective Studies | Analgesics, Non-Narcotic - pharmacokinetics | Area Under Curve | Humans | Omeprazole - blood | Acetaminophen - administration & dosage | Half-Life | Biological Availability | Bromazepam - administration & dosage | Male | Metabolic Clearance Rate | Anti-Ulcer Agents - blood | Anti-Ulcer Agents - pharmacokinetics | Anti-Anxiety Agents - pharmacokinetics | Acetaminophen - blood | Bromazepam - blood | Intubation, Gastrointestinal | Female | Analgesics, Non-Narcotic - blood | Reproducibility of Results | Administration, Oral | Omeprazole - administration & dosage | Omeprazole - pharmacokinetics | Analgesics, Non-Narcotic - administration & dosage | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | Anti-Anxiety Agents - blood | Bromazepam - pharmacokinetics | Acetaminophen - pharmacokinetics | Cohort Studies | Therapeutic Equivalency | Acetaminophen | Analysis | Pharmacy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Neonatal exposure to a combination of N-Methyl-D-aspartate and γ-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits
by Fredriksson, Anders and Pontén, Emma and Gordh, Torsten and Eriksson, Per
Anesthesiology (Philadelphia), ISSN 0003-3022, 09/2007, Volume 107, Issue 3, pp. 427 - 436
Life Sciences & Biomedicine | Anesthesiology | Science & Technology | Biological and medical sciences | Anesthesia | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Anti-Anxiety Agents - administration & dosage | Anesthetics, Intravenous - adverse effects | Apoptosis - drug effects | Male | Receptors, GABA-A | Anesthetics, Combined - adverse effects | Ketamine - administration & dosage | N-Methylaspartate - adverse effects | Ketamine - adverse effects | Anesthetics, Intravenous - administration & dosage | Time Factors | Behavior, Animal - drug effects | Propofol - administration & dosage | Thiopental - administration & dosage | Analgesics - adverse effects | Disease Models, Animal | Animals, Newborn | Diazepam - administration & dosage | Analgesics - administration & dosage | N-Methylaspartate - administration & dosage | Sodium Chloride - administration & dosage | GABA Antagonists - administration & dosage | Maze Learning - drug effects | GABA Antagonists - adverse effects | Brain - drug effects | Drug Synergism | Excitatory Amino Acid Agonists - administration & dosage | Thiopental - adverse effects | Anesthetics, Combined - administration & dosage | Animals | Neurodegenerative Diseases - chemically induced | Excitatory Amino Acid Agonists - adverse effects | Mice | Drug Combinations | Propofol - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
by Müller, N and Schwarz, M.J and Dehning, S and Douhe, A and Cerovecki, A and Goldstein-Müller, B and Spellmann, I and Hetzel, G and Maino, K and Kleindienst, N and Möller, H.-J and Arolt, V and Riedel, M
Molecular psychiatry, ISSN 1359-4184, 07/2006, Volume 11, Issue 7, pp. 680 - 684
COX-2 inhibition | Inflammation | Psychoneuroimmunology | Major depression | Immunity | Biochemistry & Molecular Biology | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Anti-Anxiety Agents - administration & dosage | Dinoprostone - analysis | Pyrazoles - therapeutic use | Adrenergic Uptake Inhibitors | Dinoprostone - biosynthesis | Humans | Middle Aged | Depressive Disorder - drug therapy | Male | Patient Dropouts | Lorazepam - therapeutic use | Inflammation - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Female | Antidepressive Agents - pharmacology | Anti-Anxiety Agents - therapeutic use | Drug Therapy, Combination | Morpholines - therapeutic use | Pyrazoles - pharmacology | Severity of Illness Index | Cyclooxygenase 2 Inhibitors - pharmacology | Double-Blind Method | Cyclooxygenase 2 Inhibitors - administration & dosage | Morpholines - administration & dosage | Lorazepam - administration & dosage | Celecoxib | Sulfonamides - pharmacology | Antidepressive Agents - therapeutic use | Pilot Projects | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Depressive Disorder - physiopathology | Serotonin - metabolism | Interleukin-6 - biosynthesis | Antidepressive Agents - administration & dosage | Psychological Tests | Sulfonamides - administration & dosage | Inflammation - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
by Schmidt, Heath D and Duman, Ronald S
Neuropsychopharmacology (New York, N.Y.), ISSN 0893-133X, 11/2010, Volume 35, Issue 12, pp. 2378 - 2391
neurogenesis | dentate gyrus | depression | serum | neurotrophic factor | antidepressant | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Anti-Anxiety Agents - metabolism | Recombinant Proteins - therapeutic use | Male | Anxiety - drug therapy | Extracellular Signal-Regulated MAP Kinases - metabolism | Hippocampus - drug effects | Antidepressive Agents - metabolism | Corpus Striatum - metabolism | Depression - drug therapy | Brain-Derived Neurotrophic Factor - pharmacology | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Neurogenesis - drug effects | Anti-Anxiety Agents - therapeutic use | Brain-Derived Neurotrophic Factor - therapeutic use | Disease Models, Animal | Recombinant Proteins - metabolism | Mice, Inbred C57BL | Anti-Anxiety Agents - pharmacology | Recombinant Proteins - pharmacology | Recombinant Proteins - administration & dosage | Infusions, Subcutaneous | Antidepressive Agents - therapeutic use | Brain-Derived Neurotrophic Factor - administration & dosage | Hippocampus - metabolism | Animals | Cyclic AMP Response Element-Binding Protein - metabolism | Corpus Striatum - drug effects | Mice | Mice, Inbred BALB C | Index Medicus | biological psychiatry | animal models | bipolar | unipolar | molecular and cellular neurobiology | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety
by Bencan, Zachary and Sledge, Damiyon and Levin, Edward D
Pharmacology, biochemistry and behavior, ISSN 0091-3057, 2009, Volume 94, Issue 1, pp. 75 - 80
Zebrafish | Chlordiazepoxide | Anxiolysis | Buspirone | Anxiolytic drugs | Diazepam | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Behavioral Sciences | Science & Technology | Psycholeptics: tranquillizer, neuroleptic | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Serotonin Agents - therapeutic use | Chlordiazepoxide - therapeutic use | Cholinergic Agents - administration & dosage | Cholinergic Agents - therapeutic use | Diazepam - administration & dosage | Serotonin Agents - administration & dosage | Imaging, Three-Dimensional - methods | Chlordiazepoxide - administration & dosage | Anxiety - drug therapy | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Animals | Time Factors | Exploratory Behavior - drug effects | Stress, Psychological | Behavior, Animal - drug effects | Benzodiazepines - administration & dosage | Diving | Anti-Anxiety Agents - therapeutic use | Diazepam - therapeutic use | Benzodiazepines - therapeutic use | Buspirone - therapeutic use | Disease Models, Animal | Sedatives | Analysis | Armored vehicles | Polybrominated biphenyls | Hypnotics | Antianxiety agents | Benzodiazepines | Index Medicus | buspirone | anxiolytic drugs | anxiolysis | diazepam | chlordiazepoxide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice
by Chaves, Raquell de Castro and Mallmann, Auriana Serra Vasconcelos and Oliveira, Natália Ferreira and Oliveira, Iris Cristina Maia and Capibaribe, Victor Celso Cavalcanti and da Silva, Daniel Moreira Alves and Lopes, Iardja Stéfane and Valentim, José Tiago and de Carvalho, Alyne Mara Rodrigues and Macêdo, Danielle Silveira and Vasconcelos, Silvânia Maria Mendes and Gutierrez, Stanley Juan Chaves and Barbosa Filho, José Maria and de Sousa, Francisca Cléa Florenço
Pharmacology, biochemistry and behavior, ISSN 0091-3057, 05/2019, Volume 180, pp. 44 - 51
Corticosterone administration | Depression | Chronic stress | Riparin | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Behavioral Sciences | Science & Technology | Anti-Anxiety Agents - administration & dosage | Corticosterone - administration & dosage | Corticosterone - pharmacology | Sucrose | Food Preferences - physiology | Anxiety - drug therapy | Ethylamines - administration & dosage | Depression - drug therapy | Benzamides - administration & dosage | Benzamides - therapeutic use | Fluvoxamine - administration & dosage | Depression - chemically induced | Behavior, Animal - drug effects | Female | Antidepressive Agents - pharmacology | Benzamides - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Anhedonia - physiology | Tyramine - analogs & derivatives | Disease Models, Animal | Amides - pharmacology | Tyramine - pharmacology | Ethylamines - pharmacology | Tyramine - therapeutic use | Anti-Anxiety Agents - pharmacology | Amides - therapeutic use | Tyramine - administration & dosage | Hindlimb Suspension | Fluvoxamine - pharmacology | Antidepressive Agents - therapeutic use | Hippocampus - metabolism | Animals | Antidepressive Agents - administration & dosage | Anxiety - chemically induced | Mice | Amides - administration & dosage | Ethylamines - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Role of serotonin in zebrafish (Danio rerio) anxiety: Relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models
by Maximino, Caio and Puty, Bruna and Benzecry, Rancés and Araújo, Juliana and Lima, Monica Gomes and de Jesus Oliveira Batista, Evander and Renata de Matos Oliveira, Karen and Crespo-Lopez, Maria Elena and Herculano, Anderson Manoel
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 83 - 97
Fear | Zebrafish | Anxiety | Serotonin | Scototaxis | Geotaxis | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Anti-Anxiety Agents - administration & dosage | Fenclonine - administration & dosage | Spiro Compounds - therapeutic use | Anxiety - drug therapy | Piperidones - therapeutic use | Serotonin - chemistry | Brain - metabolism | Pyridines - adverse effects | Fenclonine - adverse effects | Behavior, Animal - drug effects | Hyperkinesis - chemically induced | Neurons - metabolism | Serotonin 5-HT1 Receptor Antagonists - administration & dosage | Anti-Anxiety Agents - therapeutic use | Buspirone - therapeutic use | Fluoxetine - adverse effects | Disease Models, Animal | Pyridines - administration & dosage | Nerve Tissue Proteins - agonists | Piperazines - therapeutic use | Piperazines - adverse effects | Extracellular Fluid - drug effects | Brain - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Piperazines - administration & dosage | Fenclonine - therapeutic use | Spiro Compounds - administration & dosage | Piperidones - adverse effects | Hyperkinesis - metabolism | Spiro Compounds - adverse effects | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Protein Isoforms - metabolism | Protein Isoforms - agonists | Anti-Anxiety Agents - adverse effects | Buspirone - adverse effects | Fluoxetine - therapeutic use | Neurons - drug effects | Anxiety - metabolism | Pyridines - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Serotonin 5-HT1 Receptor Antagonists - adverse effects | Nerve Tissue Proteins - metabolism | Piperidones - administration & dosage | Extracellular Fluid - metabolism | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Serotonin - metabolism | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Anxiety - chemically induced | Protein Isoforms - antagonists & inhibitors | Phenols | Buspirone hydrochloride | Fluoxetine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights